This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

One reason libertarians don’t trust the government is because so many well-intentioned government programs end up either ...

Bausch Health has exited Medicaid and a federal government drug discount scheme known as 340B, a step that suggests more ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...